IPO一周资讯｜21家企业集中递表 创单周新高

Group 1: Recent IPOs - Innovative biopharmaceutical company Huazhang Bio officially listed on the Hong Kong Stock Exchange, raising approximately HKD 674 million with a market capitalization of HKD 2.586 billion [1] - Private profit-oriented general hospital group Mingji Hospital successfully listed on the Hong Kong Stock Exchange, raising approximately HKD 626 million with a market capitalization of HKD 1.472 billion [2] - State-owned cultural tourism service enterprise Impression Dahongpao successfully listed on the Hong Kong Stock Exchange, raising approximately HKD 130 million with a market capitalization of HKD 291 million [3] - Biotech company Hansai Aitai successfully listed on the Hong Kong Stock Exchange, raising approximately HKD 586 million with a market capitalization of HKD 2.369 billion [4] - Artificial intelligence company Nobikan successfully listed on the Hong Kong Stock Exchange, raising approximately HKD 303 million with a market capitalization of HKD 14.988 billion [5] - Comprehensive health service and health insurance solution provider Qingsong Health Group officially listed on the Hong Kong Stock Exchange, raising approximately HKD 1.3 billion with a market capitalization of HKD 2.91 billion [6] - Financial service provider Nanhua Futures officially listed on the Hong Kong Stock Exchange, raising approximately HKD 1.292 billion with a market capitalization of HKD 14.1 billion [7] Group 2: Upcoming IPOs - GPGPU intelligent computing solution provider Biran Technology is set to launch an IPO from December 22 to December 29, aiming to raise approximately HKD 4.855 billion [8] - AI company Zhihua Huazhang passed the listing hearing on the Hong Kong Stock Exchange, focusing on advanced general models and aiming for rapid revenue growth [8] - General GPU chip design company Tianshu Zhixin passed the listing hearing on the Hong Kong Stock Exchange, being the first in China to achieve mass production of inference and training general GPU chips [9] - Biopharmaceutical company Ruibo Bio passed the listing hearing on the Hong Kong Stock Exchange, focusing on siRNA therapy with a strong pipeline of clinical candidates [10] - Copper cathode manufacturer Jinxun Co. passed the listing hearing on the Hong Kong Stock Exchange, ranking fifth among Chinese copper producers [11][12] - Surgical robot company Jingfeng Medical passed the listing hearing on the Hong Kong Stock Exchange, developing various surgical robots for minimally invasive procedures [13] - AI large model company MiniMax passed the listing hearing on the Hong Kong Stock Exchange, providing AI solutions to over 200 million users globally [14] - Insurtech company Baige Online passed the listing hearing on the Hong Kong Stock Exchange, ranking fifth in China's scene-based internet insurance intermediaries [15] - Cold chain service provider Hongxing Cold Chain passed the listing hearing on the Hong Kong Stock Exchange, focusing on the cold food supply chain [16] Group 3: Companies Filing for IPO - Copper industrial component manufacturer Ao Jie Co. filed for an IPO on NASDAQ, aiming to raise up to USD 30 million [17] - Student accommodation provider Student Life filed for an IPO on NASDAQ, aiming to raise up to USD 29 million [18] - Comprehensive biopharmaceutical company Zai Lab filed for an IPO on the Hong Kong Stock Exchange, focusing on innovative therapies [19] - Decorative gardening product manufacturer Global Gardening filed for an IPO on the Hong Kong Stock Exchange, primarily supplying to North American retailers [20] - Satellite time-space digital solution provider Futong Technology filed for an IPO on the Hong Kong Stock Exchange, providing satellite communication solutions [21] - Smart vehicle diagnostic and charging solution provider Daotong Technology filed for an IPO on the Hong Kong Stock Exchange, focusing on AI-driven solutions [22] - Integrated micro-drive system solution provider Zhaowei Electromechanical filed for a second IPO on the Hong Kong Stock Exchange [23] - Precision medicine company GenePlus filed for an IPO on the Hong Kong Stock Exchange, focusing on AI in biomarker discovery [24] - National chain pet medical institution Ruipai Pet Hospital filed for an IPO on the Hong Kong Stock Exchange, aiming to establish a standardized pet health management system [25] - Smart agriculture solution provider Weichai Levo filed for a second IPO on the Hong Kong Stock Exchange [26] - High-speed mixed-signal chip design company Longxun Semiconductor filed for an IPO on the Hong Kong Stock Exchange, focusing on data transmission solutions [28] - Industrial AI agent provider Haizhi Technology filed for a second IPO on the Hong Kong Stock Exchange [29] - Gene therapy company Frontera Therapeutics filed for an IPO on the Hong Kong Stock Exchange, focusing on innovative gene therapy solutions [30] - Circular packaging service provider Youlesai filed for a third IPO on the Hong Kong Stock Exchange [31] - Innovative pharmaceutical technology company Xinji Pharmaceutical filed for an IPO on the Hong Kong Stock Exchange, focusing on advanced drug delivery systems [32] - Commercial display equipment company Shiyuan Electronics filed for a second IPO on the Hong Kong Stock Exchange [33] - Millimeter-wave radar supplier Chengtai Technology filed for a second IPO on the Hong Kong Stock Exchange [35] - Financial technology service provider Sifang Jingchuang filed for an IPO on the Hong Kong Stock Exchange [36] - Exhibition service provider Miaowei Exhibition filed for an IPO on the Hong Kong Stock Exchange, ranking first in overseas exhibition institutions [37] - Financial technology solution provider Yuxin Technology filed for a second IPO on the Hong Kong Stock Exchange [38] Group 4: Companies Approved for Overseas Issuance - Seven companies, including Dazhu CNC and Liuliu Guoyuan, received approval for overseas issuance and domestic unlisted shares "full circulation" applications [39]